![]() |
6th July 2008 @ 10:15pm |
| Subscribe | Instructions To Authors | Advertising/Supplements | Contact Us | Help |
|
SupplementsSupplements currently available include: New data from the FIELD study: protecting the diabetic eye The metabolic bomb is ticking – how can we defuse it? Beyond the metabolic syndrome. Academic debate; type 2 diabetes Abstracts of the 2nd International Congress on "Prediabetes" and the Metabolic Syndrome The developing role of metformin (Glucophage®) in the treatment of type 2 diabetes Vascular risk reduction in type 2 diabetes - evolving treatment paradigms Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor |